Drugs / Branched-chain Amino Acid
Branched-chain Amino Acid
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT06121492 | Nov 2023 → Jun 2026 overdue | cirrhosis of liver, muscular atrophy | Mahidol University | Enrolling by invitation | No outcome recorded |
| Phase 3 | NCT03633279 | Jun 2018 → Jan 2024 overdue | cirrhosis of liver | Dayanand Medical College and Hospital | Active not recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06538077 | Feb 2025 → Aug 2026 overdue | cirrhosis of liver, hepatic encephalopathy | Post Graduate Institute of Medical Education and Research, Chandigarh | Recruiting | No outcome recorded |
| Phase 4 | NCT02755701 | Jul 2016 → Jun 2018 | cirrhosis of liver | Soonchunhyang University Hospital | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT05724485 Comparator | Apr → Oct 2023 | cirrhosis of liver | Mahidol University | Completed | No outcome recorded |
| Phase 4 | NCT02837302 Comparator | Nov 2012 → Dec 2017 | cirrhosis of liver | Kyungpook National University Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01434524 Comparator | Apr 2007 → Oct 2008 | liver cancer | Kochi University | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Branched chain amino acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03633279 ↗ |
| Known as | BCAA | “The active drug BCAA supplement will be dispensed in a dose of 15 gm once daily x 12 weeks” NCT06538077 ↗ |
| Known as | branched-chain amino acids | “Branched-chain amino acids (BCAA) had been developed to correct this amino acid imbalance and helped to decrease the frequency of cramps and improve the quality of life in...” NCT05724485 ↗ |
| Known as | LIVACT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01434524 ↗ |
| Action | Activate | “The possible effect of Branched Chain Amino acids on sarcopenia is that leucine primarily activates the mammalian target of rapamycin signaling pathway involved in muscle...” NCT03633279 ↗ |
| Modality | Other / unclassified | “oral branched-chain amino acid supplement” NCT02837302 ↗ |
| Route | Oral | “oral supplementation with BCAA” NCT01434524 ↗ |